World Journal of Gastrointestinal Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2022-07-31 ms7000000646981835

偏重的研究方向：胃肠
经验分享：稿费多少钱啊

49 0

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2022-06-08 504528319

偏重的研究方向：肿瘤
经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2022-02-08 我恨梅斯Medsci

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：食管癌;免疫组化
经验分享：请问这个杂志的WOS号多少

46 0

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2021-05-17 zhangy

请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭

67 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2019-01-25 ysynl

没有人投这个杂志吗？一点信息都没有

150 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2020-04-17 14818c93m26暂无昵称

请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表:
投了

136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了

86 0

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2019-12-03 1781f75bccm

结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表:
投了

136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了

99 0

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2019-09-21 120a6ac7m01(暂无昵称)

投了137****6367暂无昵称 2019-08-26 00:00:00 发表:
你投了？

137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？

77 0

[GetPortalCommentsPageByObjectIdResponse(id=1235822, encodeId=c65c123582270, content=偏重的研究方向：胃肠 经验分享：稿费多少钱啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193c8146336, createdName=ms7000000646981835, createdTime=Sun Jul 31 22:09:59 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225203, encodeId=9afb122520311, content=偏重的研究方向：肿瘤 经验分享：投稿1个月了，AI发送了很多审稿人，到现在也没有一个审稿意见，很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Wed Jun 08 15:27:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191094, encodeId=fdbe119109436, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：食管癌;免疫组化 经验分享：请问这个杂志的WOS号多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Tue Feb 08 17:41:55 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966262, encodeId=79fa9662623a, content=请问有没有投中的啊 2.22投现在还在under review 毕业想撤稿了😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2ea65502954, createdName=zhangy, createdTime=Mon May 17 14:37:00 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566145, encodeId=bb1a56614542, content=没有人投这个杂志吗？一点信息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/12/28/80eebc88df7aaad2c9eb32ecfb284595.jpg, createdBy=cbef1645356, createdName=ysynl, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589105, encodeId=e26a58910511, content=请问现在有结果吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5afc5268272, createdName=14818c93m26暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580891, encodeId=9ceb580891c5, content=结果咋样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a32e2105143, createdName=1781f75bccm, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576697, encodeId=31975e669707, content=投了137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , beContent=137****6367暂无昵称 2019-08-26 00:00:00 发表: 你投了？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575337, encodeId=8a9a5e533738, content=你投了？ ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表: 没有人投这个杂志吗？一点信息都没有, beContent=ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=)]

2019-08-26 146d61a5m67暂无昵称

你投了？ ysynl 2019-01-25 发表::
没有人投这个杂志吗？一点信息都没有ysynl 2019-01-25 00:00:00 发表:
没有人投这个杂志吗？一点信息都没有

ysynl 2019-01-25 发表:: 没有人投这个杂志吗？一点信息都没有

101 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务